￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Is Erdafitinib already on the market in China?

2026-02-01 22:25:32

Check Details
Details of adverse reactions and side effects of Dacomitinib/Dozerun

2026-02-01 22:25:32

Check Details
Standard usage, dosage and taking guidelines for brigatinib/brigatinib (Embry)

2026-02-01 22:25:32

Check Details
Price of Entrectinib after medical insurance reimbursement

2026-02-01 22:25:32

Check Details
In CLL, acotinib/acalabrutinib demonstrates safety and improved survival of chemoimmunotherapy

2026-02-01 22:25:32

Check Details
MRD-guided ibrutinib plus venetoclax is effective in the treatment of R/R CLL

2026-02-01 22:25:32

Check Details
Liver function remains normal after taking Erdafitinib/Bocco for three years

2026-02-01 22:25:32

Check Details
How much does dacomitinib/dacomitinib cost approximately per month?

2026-02-01 22:25:32

Check Details
Efficacy, effects and applicable groups of brigatinib/brigatinib (Embry)

2026-02-01 22:25:32

Check Details
Related information about Entrectinib/Luo Shengquan Capsules

2026-02-01 22:25:32

Check Details
What is the general market price of a box of acalatinib/acalatinib capsules?

2026-02-01 22:25:32

Check Details
What are the main functions and effects of ibrutinib/Eco?

2026-02-01 22:25:32

Check Details
Category
相关知识